Comparison Between the Use of Phentolamine Versus Glyceryl Trinitrate for Their Effect on Renal Function in Pre-eclampsia Patients in ICU

Pre-Eclampsia; Complicating Pregnancy Clinical Trial

Official title: Comparison Between the Use of Phentolamine Versus Glyceryl Trinitrate for Their Effect on Renal Function in Pre-eclampsia Patients in ICU

Status Not yet recruiting

Clinical Trial Summary

Severe pre-eclamptic toxemia has a high incidence of renal complications. Rapid diagnosis and termination of pregnancy are still the gold standard main treatment for pre-eclampsia. Rapid control of blood pressure showed to provide protection against many adverse effects of preeclampsia as intracranial hemorrhage, subcapsular hepatic hematoma and acute kidney injury (AKI).

In Assiut university hospital ICU regimen, glyceryl trinitrate (GTN) was used primarily for this purpose. But it was accused in many cases as a cause for AKI without any other organ damage along with the severe preeclampsia disease. Some previous studies supported this assumption as , Ying-Hsuan .T. et.,al during their study of GTN on renal outcome during cardiopulmonary bypass in cardiac surgery. Phentolamine infusion is a new rising alternative for an old drug with a high safety profile.

In this research protocol the researchers will study comparative effect of glyceryl trinitrate (GTN) versus phentolamine on renal outcome in severe pre-eclampsia patients during their stay in obstetric ICU.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Eclampsia
• Pre-Eclampsia
• Pre-eclampsia Aggravated
• Pre-Eclampsia; Complicating Pregnancy
• Pregnancy Complications

• NCT number: NCT05687669
• Study type: Interventional
• Source: Assiut University
• Status: Not yet recruiting
• Phase: Phase 4
• Start date: January 12, 2023
• Completion date: June 12, 2023